SG92592G - Pharmaceutical compositions containing azanaphthalenes - Google Patents

Pharmaceutical compositions containing azanaphthalenes

Info

Publication number
SG92592G
SG92592G SG925/92A SG92592A SG92592G SG 92592 G SG92592 G SG 92592G SG 925/92 A SG925/92 A SG 925/92A SG 92592 A SG92592 A SG 92592A SG 92592 G SG92592 G SG 92592G
Authority
SG
Singapore
Prior art keywords
azanaphthalenes
pharmaceutical compositions
compositions containing
pharmaceutical
containing azanaphthalenes
Prior art date
Application number
SG925/92A
Other languages
English (en)
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/808,404 external-priority patent/US4945095A/en
Priority claimed from US06/839,308 external-priority patent/US4666922A/en
Priority claimed from US06/871,691 external-priority patent/US4801589A/en
Application filed by Schering Corp filed Critical Schering Corp
Publication of SG92592G publication Critical patent/SG92592G/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Transplantation (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SG925/92A 1985-06-18 1992-09-11 Pharmaceutical compositions containing azanaphthalenes SG92592G (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US74614985A 1985-06-18 1985-06-18
US06/808,404 US4945095A (en) 1985-12-12 1985-12-12 Method for suppressing the immune response
US06/839,308 US4666922A (en) 1985-06-18 1986-03-13 Method for modulating the immune response
US06/871,691 US4801589A (en) 1986-06-12 1986-06-12 Method for suppressing the immune response
PCT/US1986/001298 WO1986007537A2 (fr) 1985-06-18 1986-06-18 Compositions pharmaceutiques contenant des azanaphtalenes

Publications (1)

Publication Number Publication Date
SG92592G true SG92592G (en) 1992-12-04

Family

ID=27505636

Family Applications (1)

Application Number Title Priority Date Filing Date
SG925/92A SG92592G (en) 1985-06-18 1992-09-11 Pharmaceutical compositions containing azanaphthalenes

Country Status (6)

Country Link
EP (1) EP0228416B1 (fr)
JP (1) JPH0676322B2 (fr)
CA (1) CA1261754A (fr)
DE (1) DE3669656D1 (fr)
SG (1) SG92592G (fr)
WO (1) WO1986007537A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5350755A (en) * 1986-12-05 1994-09-27 Schering Corporation Compounds and methods for treating hyperproliferative skin disease
CA1309658C (fr) * 1986-12-05 1992-11-03 David J. Blythin Compositions pharmaceutiques pour le traitement des maladies hyperproliferatives de la peau
GB0614471D0 (en) 2006-07-20 2006-08-30 Syngenta Ltd Herbicidal Compounds
JP4495201B2 (ja) 2007-10-10 2010-06-30 シャープ株式会社 画像処理装置、画像形成装置、画像処理方法、画像処理プログラムおよび画像処理プログラムを記録する記録媒体
CN114163446B (zh) * 2021-12-16 2023-11-21 中山大学 一种喹啉酮骨架的pde4抑制剂及其制备方法与应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5854152B2 (ja) * 1976-03-25 1983-12-02 久光製薬株式会社 新規なナフチリジン誘導体
DE3368929D1 (de) * 1982-04-26 1987-02-12 Schering Corp 1,8-naphthyridine and 1,5,8-azanaphthyridine derivatives
US4680298A (en) * 1983-05-31 1987-07-14 Schering Corporation Tricyclic anti-allergy and use as anti-inflammatory agents
EP0144996B1 (fr) * 1983-12-14 1990-02-28 Schering Corporation Dérivés substitués de spiro pyridine, compositions pharmaceutiques les contenant et procédés pour leur préparation et compositions

Also Published As

Publication number Publication date
JPS63500100A (ja) 1988-01-14
WO1986007537A3 (fr) 1987-03-26
WO1986007537A2 (fr) 1986-12-31
JPH0676322B2 (ja) 1994-09-28
EP0228416B1 (fr) 1990-03-21
EP0228416A1 (fr) 1987-07-15
DE3669656D1 (de) 1990-04-26
CA1261754A (fr) 1989-09-26

Similar Documents

Publication Publication Date Title
GB8626808D0 (en) Pharmaceutical compositions
GB8524001D0 (en) Pharmaceutical composition
GB2174904B (en) Vasculoprotecting pharmaceutical compositions
GB8621577D0 (en) Pharmaceutical compositions
GB2171600B (en) Pharmaceutical compositions
GB8602625D0 (en) Pharmaceutical compositions
GB8618820D0 (en) Pharmaceutical compositions
EP0197752A3 (en) Pharmaceutical compositions
GB8618249D0 (en) Pharmaceutical compositions
GB8515170D0 (en) Pharmaceutical compositions
GB8602602D0 (en) Pharmaceutical compositions
IL79980A0 (en) Pharmaceutical composition containing ypsilon-interferon
GB8607848D0 (en) Pharmaceutical compositions
GB8618590D0 (en) Pharmaceutical compositions
SG92592G (en) Pharmaceutical compositions containing azanaphthalenes
GB2182561B (en) Pharmaceutical compositions
GB8610970D0 (en) Pharmaceutical compositions
GB8523531D0 (en) Pharmaceutical compositions
GB8522327D0 (en) Pharmaceutical compositions
GB8602601D0 (en) Pharmaceutical compositions
GB8618589D0 (en) Pharmaceutical compositions
GB8502887D0 (en) Pharmaceutical compositions
GB8608310D0 (en) Pharmaceutical compositions
GB8608309D0 (en) Pharmaceutical compositions
NZ217898A (en) Pharmaceutical compositions containing aroylthiazolones